The development of a potent, KDR/VEGFR2-sparing RET kinase inhibitor for treating patients with RET-dependent cancersB. Brandhuber,J. Haas,B. Tuch,K. Ebata, K. Bouhana, E. McFaddin,L. Williams,S. Winski,E. Brown, M. Burkhard, N. Nanda, R. Hamor,Francis J. Sullivan, L. Hanson,T. Morales,G. Vigers, R.D. Wallace, J. Blake,S. Andrews,S.M. RothenbergEUROPEAN JOURNAL OF CANCER（2016）引用 14|浏览36暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
